Detection of fetal mutations causing hemoglobinopathies by non-invasive prenatal diagnosis from maternal plasma
Background: Prenatal diagnosis of hemoglobinopathies enables couples at risk to have a healthy child. Currently used fetal sampling procedures are invasive with some risk of miscarriage. A non-invasive approach to obtain fetal deoxyribonucleic acid (DNA) for diagnosis would eliminate this risk. Aim:...
Main Authors: | E D′Souza, P M Sawant, A H Nadkarni, A Gorakshakar, K Ghosh, R B Colah |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | Journal of Postgraduate Medicine |
Subjects: | |
Online Access: | http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2013;volume=59;issue=1;spage=15;epage=20;aulast=D′Souza |
Similar Items
-
Evaluation of Novel Fetal Hemoglobin Inducer Drugs in Treatment of β-Hemoglobinopathy Disorders
by: Fatemeh Salari, et al.
Published: (2013-07-01) -
Evaluation of Novel Fetal Hemoglobin Inducer Drugs in Treatment of β-Hemoglobinopathy Disorders
by: Ali Dehghani Fard, et al.
Published: (2013-09-01) -
A Non-invasive Prenatal Diagnosis Method: Free Fetal DNA in Maternal Plasma
by: Ebru Dundar Yenilmez, et al.
Published: (2013-06-01) -
Non-Invasive Prenatal Testing: Current Perspectives and Future Challenges
by: Luigi Carbone, et al.
Published: (2021-12-01) -
Impact of Cell-Free Fetal DNA Screening on Patients’ Choice of Invasive Procedures after a Positive California Prenatal Screen Result
by: Forum T. Shah, et al.
Published: (2014-07-01)